EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.25X leverage
Performance
- Low
- ₹1,385
- High
- ₹1,404
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,520
- Open Price₹1,396
- Previous Close₹1,404
- Volume122,772
Investment Returns
- Over 1 Month + 5.4%
- Over 3 Month + 1.86%
- Over 6 Month + 4.66%
- Over 1 Year + 1.72%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 33.4
- PEG Ratio
- 0.8
- Market Cap Cr
- 26,467
- P/B Ratio
- Average True Range
- 46.24
- EPS
- 42.32
- Dividend Yield
- 0.2
- MACD Signal
- 10.49
- RSI
- 52.55
- MFI
- 32.67
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,396.20
-7.3
(-0.52%)
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹1,387.95
- 50 Day
- ₹1,374.85
- 100 Day
- ₹1,354.82
- 200 Day
- ₹1,337.85
Resistance and Support
1395.07
- R3 1,424.13
- R2 1,414.07
- R1 1,405.13
- S1 1,386.13
- S2 1,376.07
- S3 1,367.13
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,396 As on 06 December, 2025 | 01:42
The Market Cap of Emcure Pharmaceuticals is ₹26467 Cr As on 06 December, 2025 | 01:42
The P/E ratio of Emcure Pharmaceuticals is 33.4 As on 06 December, 2025 | 01:42
The PB ratio of Emcure Pharmaceuticals is 6.4 As on 06 December, 2025 | 01:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.